Principles, property rights, and profits: Historical reflections on university/industry tensions

Accountability in Research

Volumn 8, Issue 4, 2001, Pages 293-307

  Kevles, Daniel J ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Declaration of Helsinki; Drug development; Informed consent; Institutional review boards

Indexed keywords

ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; BIOTECHNOLOGY; CONFLICT OF INTEREST; ECONOMICS; FINANCIAL MANAGEMENT; GOVERNMENT REGULATION; HUMAN; INDUSTRY; INTERPERSONAL COMMUNICATION; MEDICAL RESEARCH; PATENT; UNITED STATES; UNIVERSITY;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

BIOMEDICAL RESEARCH; BIOTECHNOLOGY; CONFLICT OF INTEREST; DISCLOSURE; FINANCING, GOVERNMENT; GOVERNMENT REGULATION; HUMANS; INDUSTRY; PATENTS; RESEARCH SUPPORT; UNITED STATES; UNIVERSITIES;

EID: 0035552503     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/08989620108573982     Document Type: Article

References (56)

1. American Association for the Advancement of Science, Committee on Patents, Copyrights and Trademarks. (1934). The Protection by Patents of Scientific Discoveries, New York: The Science Press.
2. Apple, R. D. (1989). Patenting university research: Harry Steenbock and the Wisconsin Alumni Research Foundation, Isis 80:375-394.
3. Atkinson, S. (1990). Office of Technology Licensing, Harvard Medical School. Interview by author.
4. Baltimore, D. (1976). Testimony, US Congress, Senate, Joint Hearing. Oversight Hearing on Implementation of NIH Guidelines Government Recombinant DNA Research, 94th Cong., 2nd sess., 22 Sept.
5. Biotechnology firms and academics meet on research accords (1982). Wall Street Journal, 3 Aug., 16.
6. Bliss, M. (1982). The Discovery of Insulin. Chicago: University of Chicago Press.
7. Blue chips for a biochemist (1981). Time, 9 March, 57.
8. Bremer, H. W. (1980). Statement, U.S. Congress, House. Hearings before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary. Industrial Innovation and Patent and Copyright Law Amendments, 96th Cong., 2nd sess., 3, 15, 17, 22 April, 8 May, 9 June.
9. Brief Amicus Curiae of the Regents of the University of California. (1980). Diamond v. Chakrabarty, 447 U.S. 303.
10. Brief of Dr. Leroy Hood, Dr. Thomas Maniatis, Dr. David S. Eisenberg, the American Society of Biological Chemists, the Association of American Medical Colleges, the California Institute of Technology, the American Council on Education as Amicus Curiae (1980) Diamond v. Chakrabarty, 447 U.S. 303.
11. Cameron, F. (1952). Cottrell: Samaritan of Science. Garden City, NY: Doubleday.
12. Chase, M. (1979). Search for "superbugs": Industry sees a host of new products emerging from its growing research in gene transplants. Wall Street Journal. 10 May, 48.
13. Christensen, K. (1980). Labs and ledgers: Gene splicers develop a product: New breed of scientist-tycoons. Wall Street Journal. 24 Nov., 1, 27.
14. Clark, M. with Contreras, J. (1978). Newsweek, 18 September, 93.
15. Culliton, B. J. (1982). The Hoechst department at Mass General. Science, 11 June, 1201.
16. Dembart, L. (1982). Industry academics consider profits of biotechnology. Los Angeles Times, 26 March, 3, 17.
17. Dickson, D. (1984). The New Politics of Science. New York: Pantheon.
18. Dunner, D. R. (1980) Statement, U.S. Congress, House, Hearings before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary. Industrial Innovation and the Patent and Copyright Law Amendments, 96th Cong., 2nd sess., 3, 15, 17, 22 April, 8 May, 9 June.
19. Du Pont will give Harvard Medical School $6 million for molecular genetic research. (1981). Wall Street Journal, 20 June, 6.
20. Etkowitz, H. (1983). Entrepreneurial scientists and entrepreneurial universities in American academic science. Minerva 21:198, 225-226.
21. Etkowitz, H. (1990). MIT's relations with industry: Origins of the venture capital firm. Unpublished paper.
22. Fink, G. (1993). Precedents and comparisons. Lecture presented at National Research Council, Commission on Life Sciences, Board on Biology. Workshop on Sharing of Laboratory Resources in Biological Research: A Case Study of Genetically Altered Mice, 22-23 March, at National Academy of Sciences, Washington, D.C.
23. Fiske, E. B. (1982). Monsanto research pact aims to cut academic controversy. New York Times. 4 June, 21.
24. Frederickson, D. (1976). Statement and testimony, US Congress, Senate, Joint Hearing. Oversight Hearing on Implementation of NIH Guidelines Governing Recombinant DNA Research, 94th Cong., 2nd sess., 22 September.
25. Gray, G. W. (1936). Science and profits. Harper's, April, 539-549.
26. Hall, S. S. (1987). Invisible Frontiers: The Race to Synthesize a Human Gene. New York: The Atlantic Monthly Press.
27. Harvard abandons plans to establish gene-splicing firm. (1980). Wall Street Journal, 18 Nov., 21.
28. Harvard backs off recombinant DNA. (1980) Nature, 4 December, 423-424.
29. Harvard considers commercial role in DNA research. (1980). New York Times, 27 Oct., 1, 17.
30. Harvard University. (1975). A Statement of Policy in Regard to Patents and Copyrights as Adopted by the President and Fellows on November 3, 1975.
31. Harvard University. (1935). A Statemtent of Policy in Regard to Patents on Discoveries or Inventions Bearing on Health and Therapeutics, Conforming to Action of the President and Fellows on May 28, 1934, and May 20, 1935.
32. Heilbron, J. L., and Seidel, R. (1989). Lawrence and His Laboratory. Berkeley: University of California Press.
33. Kenney, M. (1986). Biotechnology: The University-Industrial Complex. New Haven, Conn.: Yale University Press.
34. King, J. (1982). Patenting modified life forms: The case against. Environment 24:38-40.
35. Knight, M. (1980). Harvard rules out role for now in genetic engineering company. New York Times, 18 Nov., A1, C6.
36. Kohler, R. (1994). Drosophila exchange network. In Lord of the Fly. Chicago: University of Chicago Press
37. Krimsky, S. (1982). Genetic Alchemy: The Social History of the Recombinant DNA Controversy. Cambridge, Mass.: MIT Press.
38. Lancaster, H. (1980). Rights to life: Profits in gene splicing bring the tangled issue of ownership to the fore. Wall Street Journal, 3 Dec, 1.
39. Leslie, S. W. (1994). The Cold War and American Science. New York: Columbia University Press.
40. Lynch, M. C. (1980). Harvard's plan for gene-splicing company meets with scorn from other institutions. Wall Street Journal, 12 Nov., 37.
41. Potter, A. A. (1940) Research and invention in engineering colleges. Science, 5 Jan., 4-7.
42. Railsback, T. (1980). Remarks, U.S. Congress, House. Congressional Record, 17 Nov., 29897.
43. Reinhold, R. (1980). There's gold in them thar recombinant genetic bits. New York Times, 22 June, E8.
44. Reinhold, R. (1981). Government scrutinizes link between genetics industry and universities. New York Times. 16 June, 15-16.
45. Roberts, L. (1992). NIH gene patents, round two. Science, 21 Feb., 912-913.
46. Sanger, D. E. (1980). Harvard shuns the apple but doesn't step on the serpent. New York Times, 23 Nov., E7.
47. Stanford sets fee on use of methods for gene splicing. Wall Street Journal, 3 Aug., 5.
48. The ties that bind or benefit. (1980). Nature, 10 Jan., 130-131.
49. Wade, N. ([1977] 1981). Gene splicing: At grass roots level a hundred flowers bloom. Reprint in The DNA Story: A Documentary History of Gene Cloning, San Francisco: W.H. Freeman.
50. Wade, N. (1980a). Supreme Court hears argument on patenting life forms. Science, 4 April, 31-32.
51. Wade, N. (1980b). Cloning gold rush turns basic biology into big business. Science, 16 May, 688-692.
52. Wade, N. (1980c). Gene goldrush splits Harvard, worries brokers. Science, 21 Nov., 878-879.
53. Weiner, C. (1986). Professors, and patents: A continuing controversy, Technology Review 89:33-43.
54. Weiner, C. (1987). Patenting and academic research: Historical case studies. Science, Technology, and Human Values 12:50-56.
55. W.R. Grace to fund research by MIT on biotechnology. Wall Street Journal. 3 Aug., 16.
56. Wright, S. (1986). Recombinant DNA technology and its social transformation, 1972-1982. Osiris, 2nd sen, 2:303-360.